When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
B. Riley analyst Mayank Mamtani says Acasti Pharma's (NASDAQ:ACST) 24% pullback yesterday was "unwarranted" as the delay in CaPre drug data is likely "inconsequential" to the anticipated study results.
More news on: Acasti Pharma Inc., Healthcare stocks news, Stocks on the move,